{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T09:19:46Z","timestamp":1787649586861,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["SONATA, 2020\/39\/D\/NZ5\/02330"],"award-info":[{"award-number":["SONATA, 2020\/39\/D\/NZ5\/02330"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbamcr.2026.120205","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T23:30:43Z","timestamp":1786145443000},"page":"120205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolism alterations accompany the invasive phenotype of melanoma cells resistant to BRAF\/MEK inhibitors"],"prefix":"10.1016","volume":"1873","author":[{"given":"Magdalena","family":"Kot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Simiczyjew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Pietraszek-Gremplewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Majkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Zi\u0119tek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafa\u0142","family":"Matkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamcr.2026.120205_bb0005","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/modpathol.2017.104","article-title":"Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine","volume":"31","author":"Cheng","year":"2018","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbcan.2019.02.002","article-title":"Many ways to resistance: how melanoma cells evade targeted therapies","volume":"1871","author":"Kozar","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1758834015616934","article-title":"Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy","volume":"8","author":"Eroglu","year":"2016","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-024-01788-3","article-title":"Characterization of two melanoma cell lines resistant to BRAF\/MEK inhibitors (vemurafenib and cobimetinib)","volume":"22","author":"Kot","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0030","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-025-02452-0","article-title":"Phenotype switching in highly invasive resistant to vemurafenib and cobimetinib melanoma cells","volume":"23","author":"Simiczyjew","year":"2025","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0035","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/pcmr.12021","article-title":"Mitophagy or how to control the Jekyll and Hyde embedded in mitochondrial metabolism: Implications for melanoma progression and drug resistance","volume":"25","author":"Soengas","year":"2012","journal-title":"Pigm. Cell Melanoma Res."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102995","article-title":"Metabolic rewiring in melanoma drug-resistant cells","volume":"153","author":"Bristot","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0045","author":"R: The R Project for Statistical Computing"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0050","series-title":"ggplot2","author":"Wickham","year":"2016"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116841","article-title":"Inhibition of glycolysis and Src\/Akt signaling reduces Caveolin-1-enhanced metastasis","volume":"176","author":"Sim\u00f3n","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0005-2728(03)00110-5","article-title":"Rhodamine 123 as a probe of mitochondrial membrane potential: evaluation of proton flux through F0 during ATP synthesis","volume":"1606","author":"Baracca","year":"2003","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010482","article-title":"Is the mitochondrial membrane potential (\u2206\u03a8) correctly assessed? Intracellular and intramitochondrial modifications of the \u2206\u03a8 probe, rhodamine 123","volume":"23","author":"Zorova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0070","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.90926.2008","article-title":"Acyl-coenzyme A:cholesterol acyltransferases","volume":"297","author":"Chang","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0075","doi-asserted-by":"crossref","first-page":"10339","DOI":"10.1073\/pnas.92.22.10339","article-title":"VIP21\/caveolin is a cholesterol-binding protein","volume":"92","author":"Murata","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0080","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1091\/mbc.10.4.961","article-title":"Extraction of cholesterol with methyl-\u03b2-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles","volume":"10","author":"Rodal","year":"1999","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0085","doi-asserted-by":"crossref","first-page":"32670","DOI":"10.1021\/acsami.9b09886","article-title":"Antitumor effect of lonidamine-polypeptide-peptide nanoparticles in breast cancer models","volume":"11","author":"Cohen-Erez","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ijc.32756","article-title":"Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment","volume":"147","author":"Zhou","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117071","article-title":"Benserazide-mediated targeting hexokinase 2 enhances the cytotoxicity of cisplatin in non-small cell lung cancer cell models","volume":"239","author":"Wang","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0100","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10585-024-10269-3","article-title":"The movement of mitochondria in breast cancer: internal motility and intercellular transfer of mitochondria","volume":"41","author":"Libring","year":"2024","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/pcmr.12661","article-title":"Metabolic strategies of melanoma cells: mechanisms, interactions with the tumor microenvironment, and therapeutic implications","volume":"31","author":"Fischer","year":"2018","journal-title":"Pigm. Cell Melanoma Res."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0110","series-title":"Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis","first-page":"423","author":"Parmenter","year":"2014"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0120","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.tcb.2023.03.009","article-title":"Mitochondria in cancer stem cells: Achilles heel or hard armor","volume":"33","author":"Zheng","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0125","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pharmthera.2013.12.003","article-title":"The role of FAK in tumor metabolism and therapy","volume":"142","author":"Zhang","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0130","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1080\/15384101.2016.1175258","article-title":"The metabolic microenvironment of melanomas: prognostic value of MCT1 and MCT4","volume":"15","author":"Pinheiro","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0135","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrc3365","article-title":"Mitochondria and cancer","volume":"12","author":"Wallace","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-016-0558-7","article-title":"Caveolin-1 in the regulation of cell metabolism: a cancer perspective","volume":"15","author":"Nwosu","year":"2016","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0145","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1158\/0008-5472.CAN-06-0983","article-title":"Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice","volume":"66","author":"Rofstad","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0150","article-title":"Fundamentals of cancer metabolism","volume":"2","author":"De Berardinis","year":"2016","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0155","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1242\/jcs.181016","article-title":"Cancer metabolism at a glance","volume":"129","author":"Vazquez","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155614","article-title":"Roles of malate and aspartate in gluconeogenesis in various physiological and pathological states","volume":"145","author":"Hole\u010dek","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0165","doi-asserted-by":"crossref","first-page":"20051","DOI":"10.1016\/S0021-9258(18)94588-6","article-title":"Feasibility of a mitochondrial pyruvate malate shuttle in pancreatic islets","volume":"270","author":"MacDonald","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-45586-y","article-title":"Comprehensive transcriptomic characterization of two melanoma cell lines with acquired dual resistance to BRAF and MEK inhibitors","volume":"16","author":"Kujawa","year":"2026","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0175","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41416-019-0628-x","article-title":"Increased inflammatory lipid metabolism and anaplerotic mitochondrial activation follow acquired resistance to vemurafenib in BRAF-mutant melanoma cells","volume":"122","author":"Delgado-Go\u00f1i","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114775","article-title":"Multivariate analysis of metabolic state vulnerabilities across diverse cancer contexts reveals synthetically lethal associations","volume":"43","author":"Abecunas","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0185","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.semcancer.2019.07.016","article-title":"Metabolic flexibility in melanoma: a potential therapeutic target","volume":"59","author":"Ruocco","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.605154","article-title":"The lipid metabolic landscape of cancers and new therapeutic perspectives","volume":"10","author":"Wang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.06.001","article-title":"Role of fatty acid binding proteins (FABPs) in cancer development and progression","volume":"62","author":"McKillop","year":"2019","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-2297-3","article-title":"Lipid droplets: platforms with multiple functions in cancer hallmarks","volume":"11","author":"Cruz","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0205","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-017-0473-y","article-title":"Perilipins: a diversity of intracellular lipid droplet proteins","volume":"16","author":"Itabe","year":"2017","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a004838","article-title":"Not just fat: the structure and function of the lipid droplet","volume":"3","author":"Fujimoto","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.927118","article-title":"Targeting of the lipid metabolism impairs resistance to BRAF kinase inhibitor in melanoma","volume":"10","author":"Vergani","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12113147","article-title":"Lipid metabolic reprogramming: role in melanoma progression and therapeutic perspectives","volume":"12","author":"Pellerin","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073481","article-title":"Targeting protein translation in melanoma by inhibiting EEF-2 kinase regulates cholesterol metabolism though SREBP2 to inhibit tumour development","volume":"23","author":"Dinavahi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0230","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.R200021-JLR200","article-title":"Lipid rafts: bringing order to chaos","volume":"44","author":"Pike","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0235","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.atherosclerosis.2011.10.016","article-title":"Lipid rafts: a signalling platform linking lipoprotein metabolism to atherogenesis","volume":"221","author":"Lemaire-Ewing","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0240","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1111\/j.1582-4934.2008.00568.x","article-title":"Invadopodia biogenesis is regulated by caveolin-mediated modulation of membrane cholesterol levels","volume":"13","author":"Caldieri","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0245","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40659-023-00443-4","article-title":"ABCA1 transporter promotes the motility of human melanoma cells by modulating their plasma membrane organization","volume":"56","author":"Wu","year":"2023","journal-title":"Biol. Res."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0250","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-80874-5","article-title":"Loss of fatty acid-binding protein 7 promotes B16F10 melanoma metastasis","volume":"15","author":"Wannakul","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0255","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cell.2024.10.047","article-title":"ACSL4 and polyunsaturated lipids support metastatic extravasation and colonization","volume":"188","author":"Wang","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0260","series-title":"FADS1\/2-mediated Lipid Metabolic Reprogramming Drives Ferroptosis Sensitivity in Triple-negative Breast Cancer","author":"Lorito","year":"2023"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0265","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-024-07098-3","article-title":"ACSL4-mediated lipid rafts prevent membrane rupture and inhibit immunogenic cell death in melanoma","volume":"15","author":"Zhao","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1374094","article-title":"Progress of the acyl-Coenzyme A thioester hydrolase family in cancer","volume":"14","author":"Bai","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015540","article-title":"Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells","volume":"5","author":"Maloberti","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.737776","article-title":"PPAR-\u03b3 modulators as current and potential cancer treatments","volume":"11","author":"Chi","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0285","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clnu.2023.12.005","article-title":"Peroxisome proliferator-activated receptors: a key link between lipid metabolism and cancer progression","volume":"43","author":"Li","year":"2024","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0290","first-page":"1","article-title":"Cloxiquine, a traditional antituberculosis agent, suppresses the growth and metastasis of melanoma cells through activation of PPAR\u03b3","volume":"10","author":"Zhang","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0295","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/ijms16010950","article-title":"Diverse roles of SIRT1 in cancer biology and lipid metabolism","volume":"16","author":"Simmons","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0300","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1194\/jlr.M014647","article-title":"SIRT1 controls lipolysis in adipocytes via FOXO1-mediated expression of ATGL","volume":"52","author":"Chakrabarti","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0305","doi-asserted-by":"crossref","first-page":"320","DOI":"10.18632\/oncotarget.164","article-title":"Membrane lipids in invadopodia and podosomes: key structures for cancer invasion and metastasis","volume":"1","author":"Yamaguchi","year":"2010","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0310","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.bbalip.2017.07.009","article-title":"The perilipin family of lipid droplet proteins: gatekeepers of intracellular lipolysis","volume":"1862","author":"Sztalryd","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2019.106363","article-title":"Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism","volume":"144","author":"Kuwata","year":"2019","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0320","doi-asserted-by":"crossref","first-page":"8594","DOI":"10.1158\/0008-5472.CAN-09-2305","article-title":"Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells","volume":"69","author":"Yamaguchi","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0325","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.1038\/onc.2016.168","article-title":"Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer","volume":"35","author":"Li","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2026.120205_bb0330","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/bse0570189","article-title":"Caveolin-1, galectin-3 and lipid raft domains in cancer cell signalling","volume":"57","author":"Shankar","year":"2015","journal-title":"Essays Biochem."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0335","doi-asserted-by":"crossref","DOI":"10.1186\/s40170-020-00237-2","article-title":"The diversity and breadth of cancer cell fatty acid metabolism","volume":"9","author":"Nagarajan","year":"2021","journal-title":"Cancer Metab."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0340","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1158\/0008-5472.CAN-23-2491","article-title":"ACSL4-mediated membrane phospholipid remodeling induces integrin b1 activation to facilitate triple-negative breast cancer metastasis","volume":"84","author":"Qiu","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2026.120205_bb0345","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2022.13260","article-title":"Upregulated phospholipase D2 expression and activity is related to the metastatic properties of melanoma","volume":"23","author":"Perez-Valle","year":"2022","journal-title":"Oncol. Lett."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488926001047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488926001047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:29:37Z","timestamp":1787646577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488926001047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":68,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0167488926001047"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2026.120205","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolism alterations accompany the invasive phenotype of melanoma cells resistant to BRAF\/MEK inhibitors","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2026.120205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120205"}}